World Mind Network Offers a Daily Snapshot of Humanity
Wed, 24 Sep 2008, 17:31:03 EDT — Edited by Carly Zander
BERKELEY, Calif., Sept. 24 (SEND2PRESS NEWSWIRE) -- If the planet is becoming a global village, how do you obtain a condensed view of what fellow villagers are thinking, doing, and creating right now? Answering that question is the goal of the World Mind Network, a group and website which employs the metaphor of the human race as one giant brain to explore new ways in which, largely through Web 3.0 technologies, we can connect with others, learn about distant and exotic people and phenomena, and address major problems in new ways.

Cyberonics CEO to Keynote 2006 Neurotech Leaders Forum
Thu, 14 Sep 2006, 18:43:00 GMT — Edited by Chris Simmons
SAN FRANCISCO, Calif. - Sept. 14 (SEND2PRESS NEWSWIRE) -- Robert P. 'Skip' Cummins, chairman and CEO of Cyberonics Inc., will keynote the 2006 Neurotech Leaders Forum, to be held September 28-29, 2006 at the Crowne Plaza San Francisco International Airport. The free-speaking neurotechnology industry pioneer will share some of his experiences dealing with regulatory, technical, and marketing issues during his tenure at Cyberonics. Several other neurotechnology leaders will contribute during the conference.

Breakthrough in Medical Imaging May Be Only a Fingertip Away
Fri, 23 Sep 2005, 11:32 EDT — Edited by Christopher Simmons
COLUMBUS, OH - September 23 (SEND2PRESS NEWSWIRE) -- PHIS, Inc. announced today that two peer-reviewed international journals, Kybernetes and Functional Diagnostics, published articles that may signal the beginning of a new era in medical imaging. According to an accompanying commentary by A. J. Tchizhov, M.D., 'I am firmly convinced that most departments of functional diagnostics will widely use such methods of non-invasive diagnostics in the near future.'

Neurotechnology Entrepreneur to Keynote 2005 Neurotech Leaders Forum
Tue, 13 Sep 2005, 07:03 EDT — Edited by Christopher Simmons
SAN FRANCISCO, Calif. - September 13 (SEND2PRESS NEWSWIRE) -- Alan Levy, President and CEO of Northstar Neuroscience, Inc., will keynote the 2005 Neurotech Leaders Forum, to be held in San Francisco, CA October 20-21. Levy, founder of one of the most promising venture capital-backed neurotechnology firms, will address many of the issues involved with launching a neurotechnology startup. The fifth annual event, produced by Neurotech Reports, will be held at the Crowne Plaza San Francisco International Airport. The conference will cover a range of technologies and market segments in the neuro space, including neuromodulation, neural prostheses, neurodiagnostics, and neurostimulation.

News Article Editor: Christopher L. Simmons
Health Discovery Corporation Announces Participation in the SCIA Conference
Savannah, Ga, April 7, 2004 /Send2Press Newswire/ -- Health Discovery Corporation (OTC Bulletin Board: HDVY) today announced that David Cooper, M.D., Ph.D., President and Chief Medical Officer of Health Discovery Corporation, was one of the presenters at the Southern California Investment Association conference on Saturday April 3rd which was held in Orange County, CA. Dr. Cooper discussed the status of Health Discovery Corporation, a genomic/proteomic/biotechnology company focused on biomarker and pathway discovery for diagnostic markers and drug targets.

News Article Editor: Carly Zander
Health Discovery Corporation Announces Agreement with the University of Miami for Biomarker and Pathway Discovery in AIDS related Dementia
SAVANNAH, GA - March 23, 2004 /Send2Press Newswire/ -- Health Discovery Corporation (OTC Bulletin Board: HDVY) today announced the signing of an Agreement with The University of Miami to use Health Discovery Corporations proprietary and patent protected Fractal Genomics Modeling (FGM) techniques to identify new patterns of biomarkers in AIDS Related Dementia. It is hoped that this newly discovered information will allow physicians to better understand the pathogenesis of AIDS Related Dementia and will assist in the diagnosis and treatment of this devastating disease.

[Business & Technology News Editor: Carly Zander]
Dr. Herbert A. Fritsche, Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at M.D. Anderson Cancer Center accepts position as Chairman of the Scientific Advisory Board of Health Discovery Corporation
WACO, Texas - Jan. 27, 2004 /Send2Press Newswire/ -- Health Discovery Corporation (OTC Bulletin Board: HDVY), a systems biology oriented biomarker and pathway discovery company, which uses proprietary advanced mathematical platforms, such as Fractal Genomics Modeling (FGM) techniques, to help identify and characterize diagnostic targets and therapeutic drug candidates from complex genomic, proteomic and clinical data sets, is honored that Dr. Herbert Fritsche of M.D. Anderson Cancer Center has accepted the position as Chairman of the Company's Scientific Advisory Board joining other distinguished members including Dr. Kary Mullis, recipient of the Nobel Prize for his invention of PCR.
> READ NEWS ARTICLE

[Business & Technology News Editor: Carly Zander]
Health Discovery Corporation Announces Agreement With M.D. Anderson Cancer Center for Biomarker and Pathway Discovery in Prostate Cancer
WACO, Texas - Jan. 26, 2004 /Send2Press Newswire/ -- Health Discovery Corporation (OTC Bulletin Board: HDVY) today announced the signing of its second Biomarker and Pathway Discovery Agreement with The University of Texas, M.D. Anderson Cancer Center in Houston Texas. Under the terms of the Agreement, The University of Texas, M.D. Anderson Cancer Center, has granted the Company a first option to obtain an exclusive worldwide royalty- bearing commercial license to commercialize any discovered prostate cancer biomarkers or pathways identified by the Company utilizing its proprietary and patent protected Fractal Genomics Modeling (FGM) techniques.
> READ NEWS ARTICLE

[Business & Technology News Editor: Carly Zander]
Health Discovery Corporation Releases Shareholder Letter
WACO, Texas - January 8, 2004 /Send2Press Newswire/ -- Health Discovery Corporation, Inc. (OTC BB: HDVY) today released a letter to the shareholders from Dr. Stephen D. Barnhill Chairman and Chief Executive officer of Health Discovery corporation.
> READ NEWS ARTICLE

[Business & Technology News Editor: Carly Zander]
Health Discovery Corporation Completes the Acquisition of Fractal Genomics
WACO, Texas - January 2, 2004 /Send2Press Newswire/ -- Health Discovery Corporation, Inc. (OTCBB: HDVY) today announced the completion of the acquisition of Fractal Genomics in San Francisco, California. Fractal Genomics was founded by Sandy Shaw, a former bioinformatics specialist at the University of California, San Francisco and former computer scientist and software engineer with over twenty years of experience at Bell Labs, Lockheed Electronics and the University of Hawaii. As part of the acquisition, Sandy Shaw has assumed the position of Vice-President-Fractal Technology with Health Discovery Corporation.
> READ NEWS ARTICLE

[Neurotech News Editor: Christopher Simmons, Senior Editor]
Dr. Tin-Chuen Yeung Named To Health Discovery Corporation Scientific Advisory Board
WACO, Texas - Nov. 25, 2003 /Send2Press Newswire/ -- Health Discovery Corporation (OTC Bulletin Board: HDVY), a biotechnology company which is focused on biomarker and pathway discovery for diagnostic markers and drug targets today announced the appointment of Dr. Tin-Chuen Yeung to its Scientific Advisory Board.
> READ NEWS ARTICLE   > PDF

[Newswire Editor: Christopher Simmons, Senior News Editor]
Health Discovery Corporation, Inc. Announces the Appointment of Joe Fanelli to the Management Team as Director of Corporate Development
WACO, Texas - Nov. 14, 2003 /Send2Press Newswire/ -- Health Discovery Corporation, Inc. (OTC BB: HDVY), today announced the appointment of Joe Fanelli to the Company's Management Team. Mr. Fanelli will assume the position of Director of Corporate Development for the Company. In this role, Mr. Fanelli will work on strategic alliances, partnerships, acquisitions, and licensees for the Company's patent protected biomarker discoveries.
> READ NEWS ARTICLE   > PDF